Is long-term beta-blocker therapy for myocardial infarction survivors still relevant in the era of primary percutaneous coronary intervention?

Israel Medical Association Journal

Volumn 15, Issue 12, 2013, Pages 770-774

  Shacham, Yacov ^a   Leshem Rubinow, Eran ^a   Roth, Arie ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Acute myocardial infarction (AMI); Beta blockers; Ischemia; Primary percutaneous coronary intervention (PCI); Reperfusion

Indexed keywords

ADRENERGIC BETA-ANTAGONISTS; COMPARATIVE EFFECTIVENESS RESEARCH; ELECTROCARDIOGRAPHY; HUMANS; MORTALITY; MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVORS; THROMBOLYTIC THERAPY; TIME;

EID: 84893100867     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST segment elevation with ST-segment elevation. Eur Heart J 2012; 33 (20): 2569-2619.
2. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61 (4): 78-140.
3. Hjalmarson A, Herlitz J, Holmberg S, et al. The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983; 67: 26-32.
4. The Norwegian Multicenter Study Group. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 1981; 304: 801-807.
5. β-Bblocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982; 247: 1707-1714.
6. The MIAMI trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomized trial of proanolol in patients with acute myocardial infarction. A randomised placebo-controlled international trial. Eur Heart J 1985; 6: 199-226.
7. ISIS-1 Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986; 2: 57-66.
8. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade afer myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318: 1730-177.
9. Peter T, Norris RM, Clarke ED, et al. Reduction of enzyme levels by propranolol afer acute myocardial infarction. Circulation 1978; 57: 1091-1095.
10. Roberts R, Crof C, Gold HK, et al. Efect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial. N Engl J Med 1984; 311: 218-225.
11. Aupetit JF, Frassati D, Bui-Xuan B, Freysz M, Faucon G, Timour Q. Efcacy of a beta-adrenergic receptor antagonist, propranolol, in preventing ischaemic ventricular fbrillation: dependence on heart rate and ischaemia duration. Cardiovasc Res 1998; 37 (3): 646-655.
12. Muller CA, Opie LH, Pineda CA, Peisach M. Bucindolol, a beta blocker, decreased ventricular fbrillation and maintained mechanical function in a pig model of acute myocardial ischemia.Cardiovasc Drugs Ter 1992; 6 (3): 233-237.
13. Hjalmarson A. Efects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period. Am J Cardiol 1997; 80: 35-39.
14. Wolf SC, Sauter G, Preyer M, et al. Infuence of nebivolol and metoprolol on infammatory mediators in human coronary endothelial or smooth muscle cells. Efects on neointima formation afer balloon denudation in carotid arteries of rats treated with nebivolol. Cell Physiol Biochem 2007; 19: 129-136.
15. Kern MJ, Ganz P, Horowitz JD, et al. Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease. Circulation 1983; 67: 1178-1185.
16. Viscoli CM, Horwitz RI, Singer BH. Beta-blockers afer myocardial infarction: infuence of frst-year clinical course on long-term efectiveness. Ann Intern Med 1993; 118: 99-105.
17. Gheorghiade M, Schultz L, Tilley B, Kao W, Goldstein S. Efects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol 1990; 66: 129-133.
18. Report of Te Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: a randomized, double blind, placebo controlled comparison of recurrent ischaemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986; 56: 400-143.
19. Goldman L, Sia ST, Cook EF, Rutherford JD, Weinstein MC. Costs and efectiveness of routine therapy with long-term beta-adrenergic antagonists afer acute myocardial infarction. N Engl J Med 1988; 319: 152-157.
20. Roberts R, Rogers WJ, Mueller HS, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Trombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation 1991; 83: 422-437.
21. Chen ZM, Pan HC, Chen Y P, et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet 2005; 366: 1622-1632.
22. Dargie HJ. Efect of carvedilol on outcome afer myocardial infarction in patients with lef-ventricular dysfunction: the CAPRICORN randomized trial. Lancet 2001; 357: 1385-1390.
23. Halkin A, Grines CL, Cox DA, et al. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004; 43: 1780-1787.
24. Harjai KJ, Stone G W, Boura J, et al. Efects of prior beta-blocker therapy on clinical outcomes afer primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 2003; 91: 655-660.
25. Kernis SJ, Harjai KJ, Stone G W, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction afer successful primary angioplasty? J Am Coll Cardiol 2004; 43: 1773-1779.
26. Ozasa N, Kimura T, Morimoto T, et al. Lack of efect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction afer primary percutaneous coronary intervention. Am J Cardiol 2010; 106: 1225-1233.
27. Siu C W, Pong V, Jim MH, et al. Beta-blocker in post-myocardial infarct survivors with preserved lef ventricular systolic function. Pacing Clin Electrophysiol 2010; 33: 675-860.
28. Bangalore S, Steg G, Deedwania P, et al. Beta-blocker use and clinical outcomes in stable outpatients with and without coronary artery disease. JAMA 2012; 308: 1340-1349.